On Friday, the S&P/ASX 200 Index (ASX: XJO) finished the week in a subdued fashion. The benchmark index rose by a modest 1.7 points to 7,114.5 points.

Will the market be able to build on this on Monday? Here are five things to watch:

ASX 200 expected to fall

The Australian share market looks set to fall on Monday following a poor night on Wall Street on Friday. According to the latest SPI futures, the ASX 200 is expected to open the day 29 points or 0.4% lower this morning. On Wall Street, the Dow Jones was down 0.85%, the S&P 500 dropped 1.3%, and the NASDAQ tumbled 2%.

Oil prices rise

Energy producers Santos Ltd (ASX: STO) and Woodside Energy Group Ltd (ASX: WDS) will be on watch after oil prices edged higher on Friday. According to Bloomberg, the WTI crude oil price is up 0.3% to US$90.77 a barrel and the Brent crude oil price rose 0.1% to US$96.72 a barrel. However, this couldn’t stop oil prices from recording weekly declines.

NIB results

The NIB Holdings Limited (ASX: NHF) share price will be one to watch on Monday when the private health insurer releases its full year results. According to CommSec, the market is expecting the company to report a net profit after tax of $131 million. This is expected to underpin a final dividend of 9.5 cents per share.

Gold price falls

Gold miners Newcrest Mining Limited (ASX: NCM) and Northern Star Resources Ltd (ASX: NST) could have a tough start to the week after the gold price dropped on Friday night. According to CNBC, the spot gold price was down 0.6% to US$1,760.30 an ounce. A strong US dollar put pressure on the precious metal last week, leading to five daily declines out of five. This is its longest losing run since November.

Cochlear rated as a buy

The Cochlear Limited (ASX: COH) share price could be heading higher from here according to analysts at Goldman Sachs. This morning the broker has reiterated its buy rating and lifted its price target on the hearing solutions company’s shares to $247.00. Goldman is feeling confident on Cochlear’s outlook, noting that it sees “clear scope for COH to deliver at the upper-end of another solid guidance (+8-13% to $290-305m).”

The post 5 things to watch on the ASX 200 on Monday appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• 2 years on, how close is the Flight Centre share price to its pre-COVID levels?
• ASX reporting season weekly wrap: Winners and losers
• Here are the top 10 ASX 200 shares today
• Is the AGL share price in the buy zone following the company’s latest results?
• Here are the 3 most heavily traded ASX 200 shares on Friday

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Cochlear Ltd. The Motley Fool Australia has recommended Cochlear Ltd. and NIB Holdings Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/bu9xl1T

The Australian share market is home to a number of companies with the potential to grow at a strong rate in the future.

Two such shares that analysts rate highly are listed below. Here’s what you need to know about these ASX shares:

Allkem Ltd (ASX: AKE)

The first growth share that is rated highly is this leading lithium miner.

Allkem, which is the result of the merger of Galaxy Resources and Orocobre, owns a collection of high-quality assets including Olaroz, Mt Cattlin, and the Sal de Vida brine project.

Thanks to strong lithium prices due to growing demand and tight supply, Allkem has delivered significant sales and earnings growth in FY 2022. Pleasingly, this is expected to continue in FY 2023 thanks to ongoing strength in prices, the end of older supply contracts at much lower prices, and increasing production.

Looking further ahead, management intends to grow its production three-fold by 2026 and command a 10% share of global lithium production over the long term. This bodes well for its earnings growth in the future.

Morgans is a big fan of the company. It has an add rating and $16.72 price target on its shares. This compares favourably to the latest Allkem share price of $12.34.

Domino’s Pizza Enterprises Ltd (ASX: DMP)

Another ASX growth share to look at is this pizza chain operator.

Over the last decade, Domino’s has been growing at a consistently solid rate thanks to the popularity of its offering and the expansion of its footprint.

And while FY 2022 is likely to be a disappointing year due to a number of headwinds, its future remains very positive. Particularly given how it plans to more than double its ~3,000 store network over the next decade in existing markets.

Citi remains positive on the company and recently retained its buy rating and $92.95 price target on the company’s shares. This implies major upside potential from the current Domino’s share price of $70.26.

The post 2 excellent ASX growth shares that analysts say are buys appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Could Porsche’s new test run threaten the outlook for ASX lithium shares?
• Top brokers name 3 ASX shares to buy today
• Here are 3 top ASX growth shares that experts are tipping as buys
• Why are ASX lithium shares having such a cracking start to the week?
• What’s boosting the Allkem share price on Monday?

Motley Fool contributor James Mickleboro has positions in Allkem Limited. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Dominos Pizza Enterprises Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/WyDVtrX

What a month it’s been for Core Lithium Ltd (ASX: CXO) shareholders.

After touching a low of 90 cents on 18 July, the ASX lithium producer’s shares rebounded to a record high of $1.665 on Tuesday.

Despite some retracement, the Core Lithium share price is still up by 47.3% in a month, after its shares closed on Friday at $1.40.

Let’s take a look at what’s been driving the company’s shares lately.

Core Lithium shares continue to surge

In mid-July, short bets against the sector were at their highest as economists forecasted a gloomy economic outlook. By 18 July, more than 8% of Core Lithium shares were being shorted.

However, a recent recovery in the market has prompted investors to close on their positions, which is positively impacting the Core Lithium share price.

Last week, the Australian Securities & Investments Commission (ASIC) released its short position report. It revealed that around 5.6% of Core Lithium shares were held in short positions.

Furthermore, an uptick across the lithium sector appears to be supporting Core Lithium shares.

Shares in lithium rivals Lake Resources NL (ASX: LKE) and Liontown Resources Ltd (ASX: LTR) are also up 94% and 63% in a month, respectively.

Core Lithium provided an update on its exploration activities this week, highlighting its progress at the Finniss Lithium Project and Anningie-Barrow Creek Project.

The news drove its shares 9.86% higher at the time.

With the company targeting the first production of spodumene concentrate by the end of 2022, this could bode well for its share price in future.

Core Lithium share price summary

Over the past 12 months, the Core Lithium share price has continued its upward trend to post a 324% gain.

In comparison, the S&P/ASX 200 Materials Index (ASX: XMJ) sector is flat over the same time frame.

Based on today’s price, Core Lithium commands a market capitalisation of roughly $2.42 billion.

The post Why has the Core Lithium share price rocketed 50% in a month? appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Could Porsche’s new test run threaten the outlook for ASX lithium shares?
• Here are the 3 most heavily traded ASX 200 shares on Wednesday
• Why is the Core Lithium share price careering 5% lower today?
• Here are the 3 most heavily traded ASX 200 shares on Tuesday
• Here are the top 10 ASX 200 shares today

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/5w3cfdo

Once upon a time, Novonix Ltd (ASX: NVX) shares were valued at $12.47. However, that was more than eight months ago — in a far different environment to what we know today.

Indeed, the battery technology company joined countless other unprofitable shares which were catapulted to all-time highs amid rampant speculation. Loose monetary policy, in the form of ultra-low interest rates, fuelled such investments into the stratosphere.

Yet, here we are less than a year later with a Novonix share price that is one-quarter of its former glory. Undoubtedly, the ‘cheap money’ tap has been turned off amid the reinstitution of interest rate increases by central banks.

Unremarkably, it’s companies caught without a positive cash flow machine of their own that have suffered the most. Unfortunately for Novonix shareholders, the once high-flying company is a member of that camp.

Cash earner or burner?

Considering profits hold greater importance in this environment, how close is Novonix to profitability? To answer that question, let’s take a look at the company’s latest quarterly activities report.

On 27 July, ASX-listed Novonix served up its accounts for the quarter ending 30 June 2022. According to the release, the battery and materials company collected $2.55 million in receipts from customers. This brought the value over the last 12 months to $9.03 million.

However, staff costs alone consumed $4.52 million in the quarter. Once other costs are added in, such as research and development, admin and the rest, Novonix’s operational cash flow for the quarter finishes up at a $7.96 million outflow.

In short, Novonix chewed through $4.75 million in the last quarter. Fortunately, the company has a considerable stash of cash, sitting at $207.08 million even after the June quarter.

Can Novonix become a profitable ASX company?

No one can predict the future, not even Novonix itself. But what is the game plan for potential future profitability? Well, it comes down to the success of the company’s synthetic graphite.

Ultimately, Novonix needs to scale its production of synthetic graphite over the coming years to increase revenue. If successful, there is some possibility that the business can achieve scale, and revenue will exceed expenses.

However, scaling takes time. At present, Novonix plans to produce 10,000 metric tonnes by 2023. Further plans would see production increase to 40,000 tonnes by 2025 and 150,000 tonnes by 2030.

As a result, ASX-listed Novonix will likely rely on its cash pile to see it through the near term. The Novonix share price is down 76% since the beginning of the year.

The post How close is ASX tech share Novonix to becoming profitable? appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Why did the Novonix share price nosedive 6% today?
• Is Novonix considered an ASX lithium share?
• Novonix share price tumbles 6% on Friday. What’s going on?
• Here are the top 10 ASX 200 shares today
• Why is the Novonix share price leaping 11% on Thursday?

Motley Fool contributor Mitchell Lawler has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/wISvDlL

Last week saw a number of broker notes hitting the wires once again. Three buy ratings that investors might want to be aware of are summarised below.

Here’s why brokers think investors ought to buy them next week:

Mineral Resources Limited (ASX: MIN)

According to a note out of Citi, its analysts have retained their buy rating and lifted their price target on this mining and mining services company’s shares to $76.00. The broker has become even more bullish on the company due to its belief that lithium prices will be higher for longer. This has led to Citi upgrading its earnings estimate materially for the coming years. And with Mineral Resources expected to provide an update on its lithium operations with its results next week, the broker suspects that consensus earnings estimates may need to be bumped higher. The Mineral Resources share price ended the week at $60.90.

Redbubble Ltd (ASX: RBL)

A note out of Morgans reveals that its analysts have retained their add rating but cut their price target on this ecommerce company’s shares to $1.65. The broker notes that Redbubble’s shares were sold off after its full year results following concerns about elevated operating expenses. While this is disappointing and the broker has adjusted its forecasts and valuation to accordingly, it still sees plenty of value in its shares at the current level. The Redbubble share price was fetching 93 cents at Friday’s close.

Treasury Wine Estates Ltd (ASX: TWE)

Analysts at Macquarie have upgraded this wine giant’s shares to an outperform rating with an improved price target of $15.00. This follows the release of a solid full year result for FY 2022 that was ahead of expectations. Macquarie was impressed with the success of Treasury Wine’s premiumisation of its portfolio and its transition away from China. This has led to the broker lifting its earnings estimates. It is now forecasting solid growth in the coming years. The Treasury Wine share price ended the week at $13.42.

The post Top brokers name 3 ASX shares to buy next week appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#43B02A”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#43B02A”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• ASX reporting season weekly wrap: Winners and losers
• Treasury Wine share price celebrates Friday with a more than two-year high
• Could these devastated ASX shares make a roaring comeback?
• Here are the top 10 ASX 200 shares today
• Why CSL, IPH, Renascor, and Treasury Wine shares are pushing higher

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended REDBUBBLE FPO. The Motley Fool Australia has recommended Treasury Wine Estates Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/Jj8hI0G

As its name might suggest, the Flight Centre Travel Group Ltd (ASX: FLT) share price was one of the worst-hit ASX 200 shares when the COVID-19 pandemic hit back in 2020.

With the rapid and unexpected shutdown of essentially the entire global travel industry, Flight Centre shares were never going to come out the other side of the pandemic (if we can call it that) unscathed.

But now we are more than halfway through 2022 and more than two years out from the start of the pandemic, how close is the Flight Centre share price to its pre-COVID levels?

Well, let’s journey back through the mists of time and take a look.

How is  Flight Cente share price cruising post-COVID?

So, back in February 2020, Flight Centre shares were flying high at around $35.50. But with the onset of the pandemic, investors were swift and brutal. Between 21 February and 19 March, Flight Centre shares fell a crippling 75% or so, bottoming out at just under $9.

The company was forced to suspend its shares from trading at the end of March to shore up capital. In early April, the company announced a massive $700 million capital raising program to keep its doors open. In this it was successful, but it resulted in massive share dilution for investors.

The Flight Centre share count almost doubled as the company raised money at a steep discount to what its shares were worth just a few months earlier.

Today, Flight Centre is going for $17.81 a share at the time of writing. That might be almost 100% up from the lows that the company hit in late March of 2020. but it’s still down around 30% from Flight Centre’s current 52-week high of $25.28 a share that we saw in October last year.

It’s also down an even more painful 50% or so from its pre-COVID levels.

What do the brokers say?

Flight Centre shares might not get anywhere close for a while yet, if ASX broker opinion is to be believed.

As my Fool colleague Tristan covered this week, most ASX brokers currently give Flight Centre shares either a neutral or a sell rating at present.

One broker in UBS is neutral, with a 12-month share price target of $18.65. But Ord Minnet is among the more bearish brokers. It is far less optimistic about the Flight Centre share price with its sell rating and share price target of just $13.18.

The post 2 years on, how close is the Flight Centre share price to its pre-COVID levels? appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• ASX reporting season weekly wrap: Winners and losers
• Here are the top 10 ASX 200 shares today
• Is the AGL share price in the buy zone following the company’s latest results?
• Here are the 3 most heavily traded ASX 200 shares on Friday
• Is this ASX 200 share ESG-challenged or a recession-proof buy?

Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Flight Centre Travel Group Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/wsYdlqk

BrainChip Holdings Ltd (ASX: BRN), like most tech companies in an early growth cycle, burns cash quarter to quarter.

The company announced it had spent 8.9% of its US$31.2 million total cash balance in its Q2 quarterly activities report posted on July 27. Meanwhile, cash receipts totalled $US1.2 million, up 500% from the previous quarter.

An influx of cash is a head start, but the question likely to be on most investors’ minds is, when will BrainChip generate earnings?

This is hard to say as a high-growth ASX tech stock in neuromorphic computing. Wall Street hasn’t taken a stab at answering this question either, with only one analyst rating the stock as a buy at the time of writing.

What we can do, though, is revise its recent commercialisation efforts as it progresses in the business cycle from startup to growth. These are signs of where the company is headed in the future and provide clues to when profitability will eventuate.

What did BrainChip announce?

Commercialisation was a key focus in its quarterly activities report, which was covered by my Foolish colleague Aaron.

The company made headway in developing its AkidaTM neuromorphic IP via several avenues, including technical scoping with several potential clients. Technical scoping is typically one of the first steps companies establish before the money exchanges hands, so this could suggest further deals are in the making.

More explicit progress was made by establishing commercial partnerships with tech companies Arm, SiFive, and Prophesee.

In a press release jointly published by SiFive and BrainChip, it was announced the companies had joined forces to offer processors that deliver BrainChip’s artificial intelligence and machine learning capabilities, known as edge computing.

BrainChip also started preliminary partnerships with AI companies Impulse and NVISO.

BrainChip share price snapshot

The BrainChip share price is up 30% year to date. On Friday, shares closed 1.9% lower at $1.03.

The company’s market capitalisation is roughly $1.81 billion.

The post When is ASX tech share BrainChip expected to become profitable? appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#43B02A”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#43B02A”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Why is the BrainChip share price sinking today?
• Here are the top 10 ASX 200 shares today
• Brainchip share price powers up another 5% on Thursday
• Why is the BrainChip share price bouncing 6% higher today?
• This US investment house has made tens of millions from Brainchip. Guess which other ASX share it’s backing

Motley Fool contributor Matthew Farley has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/DUWrflN

If you want to add some dividend shares to your portfolio, then you may want to check out the two listed below that brokers rate as buys.

Here’s what they are saying about these dividend shares:

HomeCo Daily Needs REIT (ASX: HDN)

According to a note out of Morgans, its analysts have retained their add rating and $1.56 price target on this convenience-based property company’s shares.

The broker was pleased with HomeCo Daily Needs REIT’s full year results for FY 2022 and believes the company is well-placed to build on this in the coming years. This is thanks to solid demand for its properties and its development pipeline.

Morgans is forecasting dividends of 8.3 cents per share in FY 2023 and 8.7 cents per share in FY 2024. Based on the current HomeCo Daily Needs REIT unit price of $1.29, this will mean yields of 6.4% and 6.7%, respectively.

Medibank Private Ltd (ASX: MPL)

A note out of Citi reveals that its analysts have retained their buy rating and lifted their price target on this private health insurer’s shares to $4.00.

Citi was pleased with Medibank’s full year results and particularly its private health insurance business. It expects the business’ positive performance to continue and is forecasting an outlook of largely stable margins paired with reasonable top line growth.

In addition, it notes that the Medibank Health business is targeting a profit growth rate of at least 15%, which should be supported by higher interest rates.

Overall, while the broker acknowledges that Medibank’s shares are not cheap, it feels that the company’s positive outlook makes them reasonable value at the current level.

Citi is also expecting Medibank’s shares to provide attractive yields in the near term. Its analysts are forecasting fully franked dividends of 15.9 cents per share in FY 2023 and 16.3 cents per share in FY 2024. Based on the current Medibank share price of $3.65, this will mean yields of 4.35% and 4.5%, respectively.

The post Brokers name 2 ASX dividend shares to buy appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Here are the top 10 ASX 200 shares today
• Medibank share price dips despite dividend boost
• HomeCo share price slides despite 970% profit boost
• Medibank share price on watch amid ‘standout customer growth’
• How much have Medibank shares paid in dividends over the past 5 years?

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/C0yO6fj

The CSL Limited (ASX: CSL) share price had an eventful week.

Although the biotherapeutics giant’s shares recorded a small weekly gain, that’s only telling half the story.

Following the release of the company’s full year results, the CSL share price was down as much as 6% before staging a swift recovery.

Where next for the CSL share price?

The good news is that one leading broker believes the CSL share price is heading higher from here.

According to a note out of Morgans, its analysts have retained their add rating with a trimmed price target of $321.30.

Based on the current CSL share price of $294.67, this implies potential upside of 9% for investors over the next 12 months.

What did the broker say?

CSL’s FY 2022 results were a bit of a mixed bag according to Morgans. It commented:

FY22 results were slightly softer than expected, albeit in line with management’s assumptions, with net profit falling 6% in cc on 3% revenue growth. Seqirus was the standout on strong demand for influenza vaccines, while Behring profit fell as plasma-based products were constrained on tight supply and higher costs, although certain Specialty product surprised to the upside. Encouragingly, plasma collections are above pre-pandemic levels, and while industry wide challenges remain (eg staffing; increased costs), the worst appears behind us.

And while the company’s guidance “disappointed”, the broker highlights that “underlying growth is solid (11-14%) and excludes Vifor growth.”

Overall, Morgans acknowledges that there are still some near term challenges, but appears to believe the company is well-placed to overcome them and deliver strong growth in the future. It explained:

While near term challenges remain and plasma inventories will need to be rebuilt over time, strong plasma collection growth and ongoing demand across both Behring and Seqirus underpin strong growth and continued momentum.

The post Is the CSL share price in the buy zone? appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Why I would invest $10,000 into these ASX shares for 10 years
• Brokers name 3 ASX shares to buy today
• Buy this ASX 200 company as its costs are actually falling: Firetrail
• Here are the top 10 ASX 200 shares today
• Why CSL, IPH, Renascor, and Treasury Wine shares are pushing higher

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/9IfWFbu

If you’re looking to invest in the tech sector but aren’t sure which shares to buy, then you may want to consider exchange traded funds (ETFs).

That’s because there are a number of ETFs out there that allow investors to buy a slice of some of the world’s biggest and brightest tech companies.

Two ETFs that will allow you to achieve this are listed below. Here’s what you need to know about them:

BetaShares Asia Technology Tigers ETF (ASX: ASIA)

The first ETF for tech investors to look at is the BetaShares Asia Technology Tigers ETF. This ETF gives investors exposure to some of the largest tech companies in the Asian market (excluding Japan).

BetaShares believes this is a good place for investors to put funds, noting that technological adoption in Asia is surpassing the West. Furthermore, with this trend tipped to continue in the future, this is expected to underpin strong growth in the sector over the next decade.

There are approximately 50 companies included in the fund including the likes of Alibaba, Infosys, JD.com, Meituan, Pinduoduo, Samsung, and Tencent.

In respect to the latter, Tencent is a multinational technology conglomerate and one of the largest companies in the world. It is best known for its communication and social platforms, Weixin (WeChat) and QQ, which connect over a billion users with each other.

BetaShares Global Cybersecurity ETF (ASX: HACK)

Another ASX ETF for tech investors to look at is the BetaShares Global Cybersecurity ETF. As its name implies, this popular ETF gives investors exposure to the leading companies in the global cybersecurity sector.

The cybersecurity sector has been growing strongly in recent years. Pleasingly, due to increasing demand for cybersecurity services because of the growing threat of cyber attacks and the shift to the cloud, it has been tipped to continue doing so for a long time to come.

Included in the fund are global cybersecurity giants and emerging players from around the globe. Among the companies you’ll be buying a piece of are Accenture, Cisco, Cloudflare, Crowdstrike, Okta, and Splunk.

The post Love tech? Here are 2 excellent ETFs for ASX tech investors appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#43B02A”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#43B02A”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• 2 exciting ETFs for ASX investors to buy today
• Why the BetaShares ASIA ETF is 50% below its former glory
• 3 ETFs for ASX investors to buy right now
• 2 exciting ETFs for investors to buy in August
• Why I think these ASX tech shares are buys in August

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended BETA CYBER ETF UNITS. The Motley Fool Australia has positions in and has recommended BETA CYBER ETF UNITS. The Motley Fool Australia has recommended BetaShares Asia Technology Tigers ETF. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/gdwls8F